111 related articles for article (PubMed ID: 15344954)
1. beta6 integrin is up-regulated in chronic renal allograft dysfunction.
Sawada T; Abe M; Kai K; Kubota K; Fuchinoue S; Teraoka S
Clin Transplant; 2004 Oct; 18(5):525-8. PubMed ID: 15344954
[TBL] [Abstract][Full Text] [Related]
2. Mice lacking beta6 integrin in skin show accelerated wound repair in dexamethasone impaired wound healing model.
Xie Y; Gao K; Häkkinen L; Larjava HS
Wound Repair Regen; 2009; 17(3):326-39. PubMed ID: 19660040
[TBL] [Abstract][Full Text] [Related]
3. Tubulitis in renal allograft rejection: role of transforming growth factor-beta and interleukin-15 in development and maintenance of CD103+ intraepithelial T cells.
Wong WK; Robertson H; Carroll HP; Ali S; Kirby JA
Transplantation; 2003 Feb; 75(4):505-14. PubMed ID: 12605119
[TBL] [Abstract][Full Text] [Related]
4. TNF-alpha and TGF-beta1 gene polymorphisms and renal allograft rejection in Koreans.
Park JY; Park MH; Park H; Ha J; Kim SJ; Ahn C
Tissue Antigens; 2004 Dec; 64(6):660-6. PubMed ID: 15546338
[TBL] [Abstract][Full Text] [Related]
5. Significance of early biopsy in pediatric kidney transplantation.
Ishimura T; Ishida T; Fujisawa M
Aktuelle Urol; 2003 Jul; 34(4):234-8. PubMed ID: 14566671
[TBL] [Abstract][Full Text] [Related]
6. [Expressions of transforming growth factor-beta1 and collagen IV in renal tissues of patients with chronic allograft nephropathy].
Han CX; Yu LX; Xu J; Xie QX; Wang YB; Deng WF; Liu XY; Zeng JH
Di Yi Jun Yi Da Xue Xue Bao; 2005 May; 25(5):567-9. PubMed ID: 15897139
[TBL] [Abstract][Full Text] [Related]
7. The effect of different immunosuppressive regimens on TGF-beta1 expression in kidney transplant patients.
Matl I; Viklický O; Voska L; Lodererová A; Vítko S
Transpl Int; 2005 Jun; 18(6):668-71. PubMed ID: 15910291
[TBL] [Abstract][Full Text] [Related]
8. TGF-beta1 in chronic allograft nephropathy following renal transplantation.
Harris S; Coupes BM; Roberts SA; Roberts IS; Short CD; Brenchley PE
J Nephrol; 2007; 20(2):177-85. PubMed ID: 17514622
[TBL] [Abstract][Full Text] [Related]
9. Expression of transforming growth factor-beta1 and hypoxia-inducible factor-1alpha in renal transplantation.
Lee S; Kim DJ; Park MG; Park SK; Kim JS; Hyun SJ; Oh JE; Nam ES; Joo SH
Transplant Proc; 2008 Sep; 40(7):2147-8. PubMed ID: 18790176
[TBL] [Abstract][Full Text] [Related]
10. Cytokines and chemokine gene expression in human kidney transplantation.
Hribova P; Kotsch K; Brabcova I; Vitko S; Volk HD; Lacha J
Transplant Proc; 2005 Mar; 37(2):760-3. PubMed ID: 15848523
[TBL] [Abstract][Full Text] [Related]
11. Endothelin-mediated oncofetal fibronectin expression in chronic allograft nephropathy.
Siddiqui I; Khan ZA; Lian D; Jiang J; Zhong R; Garcia B; Chakrabarti S
Transplantation; 2006 Aug; 82(3):406-14. PubMed ID: 16906041
[TBL] [Abstract][Full Text] [Related]
12. Loss of integrin alpha(v)beta6-mediated TGF-beta activation causes Mmp12-dependent emphysema.
Morris DG; Huang X; Kaminski N; Wang Y; Shapiro SD; Dolganov G; Glick A; Sheppard D
Nature; 2003 Mar; 422(6928):169-73. PubMed ID: 12634787
[TBL] [Abstract][Full Text] [Related]
13. Distinct expression of interleukin 17, tumor necrosis factor α, transforming growth factor β, and forkhead box P3 in acute rejection after kidney transplantation.
de Menezes Neves PD; Machado JR; dos Reis MA; Faleiros AC; de Lima Pereira SA; Rodrigues DB
Ann Diagn Pathol; 2013 Feb; 17(1):75-9. PubMed ID: 22963863
[TBL] [Abstract][Full Text] [Related]
14. TGF-beta1 mRNA upregulation influences chronic renal allograft dysfunction.
Pribylova-Hribova P; Kotsch K; Lodererova A; Viklicky O; Vitko S; Volk HD; Lacha J
Kidney Int; 2006 May; 69(10):1872-9. PubMed ID: 16612332
[TBL] [Abstract][Full Text] [Related]
15. Correlative insights into the immunoexpression of transforming growth factor beta-1 in acutely rejected renal allografts.
Danilewicz M; Wagrowska-Danilewicz M
Pathol Res Pract; 2006; 202(1):9-15. PubMed ID: 16343799
[TBL] [Abstract][Full Text] [Related]
16. Aberrant tubulointerstitial immunoexpression of matrix metalloproteinases MMP-2, MMP-9 and tissue inhibitor of matrix proteinase-2 (TIMP-2) in acute cellular rejection of human renal allograft.
Wagrowska-Danilewicz M; Danilewicz M
Pol J Pathol; 2008; 59(4):189-94. PubMed ID: 19391484
[TBL] [Abstract][Full Text] [Related]
17. BIGH3 is overexpressed in clear cell renal cell carcinoma.
Yamanaka M; Kimura F; Kagata Y; Kondoh N; Asano T; Yamamoto M; Hayakawa M
Oncol Rep; 2008 Apr; 19(4):865-74. PubMed ID: 18357369
[TBL] [Abstract][Full Text] [Related]
18. TGF-beta1 expression and chronic allograft nephropathy in protocol kidney graft biopsy.
Viklický O; Matl I; Voska L; Böhmová R; Jaresová M; Lácha J; Lodererová A; Stríz I; Teplan V; Vítko S
Physiol Res; 2003; 52(3):353-60. PubMed ID: 12790768
[TBL] [Abstract][Full Text] [Related]
19. FK778 ameliorates post-transplant expression of fibrogenic growth factors and development of chronic rejection changes in rat kidney allografts.
Rintala JM; Savikko J; Rintala SE; von Willebrand E
Nephrol Dial Transplant; 2008 Nov; 23(11):3446-55. PubMed ID: 18558624
[TBL] [Abstract][Full Text] [Related]
20. Association of C-509T and T869C polymorphisms of transforming growth factor-beta1 gene with chronic allograft nephropathy and graft survival in Korean renal transplant recipients.
Cho JH; Huh S; Kwon TG; Choi JY; Hur IK; Lee EY; Park SH; Kim YL; Kim CD
Transplant Proc; 2008 Sep; 40(7):2355-60. PubMed ID: 18790234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]